Nektar Therapeutics's total assets for Q3 2024 were $307.97M, a decrease of -10.30% from the previous quarter. NKTR total liabilities were $259.08M for the fiscal quarter, a -1.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.